Literature DB >> 12727363

Differential microorganism-induced mannose-binding lectin activation.

Saskia Kuipers1, Piet C Aerts, Hans van Dijk.   

Abstract

Mannose-binding lectin (MBL) is a serum complement factor playing a dominant role in first-line defense. When MBL binds to specific sugar moieties on microorganisms, the lectin complement pathway (LCP) is activated. Changes in the mbl gene and promotor may result in MBL with less activity, predisposing the individual to recurrent infections. Using a functional MBL assay, we investigated at what concentration different microbes activated MBL. Less than 1 colony-forming unit (CFU) of Neisseria meningitidis groups B and C still activated MBL, which may be ascribed to filterable blebs. Nocardia farcinica and Legionella pneumophila activated MBL well, which raises new questions about host susceptibility. In contrast to other research, Pseudomonas aeruginosa activated the LCP potently.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727363     DOI: 10.1016/S0928-8244(03)00032-4

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  14 in total

1.  Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin.

Authors:  Anders Krarup; Uffe B Skov Sørensen; Misao Matsushita; Jens C Jensenius; Steffen Thiel
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Role of YadA, Ail, and Lipopolysaccharide in Serum Resistance of Yersinia enterocolitica Serotype O:3.

Authors:  Marta Biedzka-Sarek; Reija Venho; Mikael Skurnik
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa.

Authors:  Mette Møller-Kristensen; W K Eddie Ip; Lei Shi; Lakshmi D Gowda; Michael R Hamblin; Steffen Thiel; Jens Chr Jensenius; R Alan B Ezekowitz; Kazue Takahashi
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

Review 4.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

5.  Acute-phase responsiveness of mannose-binding lectin in community-acquired pneumonia is highly dependent upon MBL2 genotypes.

Authors:  B L Herpers; H Endeman; B A W de Jong; B M de Jongh; J C Grutters; D H Biesma; H van Velzen-Blad
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

6.  Low mannose-binding lectin complement activation function is associated with predisposition to Legionnaires' disease.

Authors:  D P Eisen; J Stubbs; D Spilsbury; J Carnie; J Leydon; B P Howden
Journal:  Clin Exp Immunol       Date:  2007-04-11       Impact factor: 4.330

7.  Mannose-binding lectin 2 (Mbl2) gene polymorphisms are related to protein plasma levels, but not to heart disease and infection by Chlamydia.

Authors:  M A F Queiroz; S T M Gomes; N C C Almeida; M I M Souza; S R C F Costa; R B Hermes; S S Lima; M M Zaninotto; M A A Fossa; M A Maneschy; R N Martins-Feitosa; V N Azevedo; L F A Machado; M O G Ishak; R Ishak; A C R Vallinoto
Journal:  Braz J Med Biol Res       Date:  2016-12-12       Impact factor: 2.590

8.  Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Richard K Albert; John Connett; Jeffrey L Curtis; Fernando J Martinez; Meilan K Han; Stephen C Lazarus; Prescott G Woodruff
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-11-23

9.  Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells.

Authors:  Eveline C van Asbeck; Andy I M Hoepelman; Jelle Scharringa; Bjorn L Herpers; Jan Verhoef
Journal:  BMC Microbiol       Date:  2008-12-18       Impact factor: 3.605

10.  Activation of the lectin pathway of complement in experimental human keratitis with Pseudomonas aeruginosa.

Authors:  Michael Osthoff; Karl D Brown; David C M Kong; Mark Daniell; Damon P Eisen
Journal:  Mol Vis       Date:  2014-01-06       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.